The PROMISE of Early Detection and Interception in Myeloma

In this session, Irene Ghobrial, MD, discusses efforts to identify precursor conditions to multiple myeloma early and prevent progression to active myeloma. Many screening and treatment clinical trials are available for patients with smoldering multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS). Learn more about the Center for Prevention of Progression. www.dana-farber.org/center-fo...

[@jessicabellone913]

I just joined the PCROWD Study. I’m honored to help my fellow humans in any way I can ❤

[@ElephantsRock19]

I am extremely honored to be a member of the Promise Study! I joined in honor of my oldest brother (MM) and a sister (B-cell ALL) leukemia. If my participation helps, however minute, then I am honored beyond measure!
Thank you to everyone involved in the research for early detection and hopefully one day, a cure! 🩸🧑‍🔬🧬❤️

[@petersampson5202]

DEAR EVERYONE AT DANA-FARBER CANCER INSTITUTE,
GOD BLESS YOU MY FRIENDS. I AM VERY PROUD OF YOU AND VERY HAPPY FOR YOU. I HOPE ALL OF YOUR DREAMS COME TRUE. I LOVE YOU. I LOVE DANA-FARBER CANCER INSTITUTE. 🙏
SINCERELY PETER